A retrospective, single institution study analysing safety and efficacy of Nanoliposomal irinotecan plus fluorouracil and folinic acid in patients with metastatic pancreatic ductal adenocarcinoma
Latest Information Update: 22 Feb 2022
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Irinotecan (Primary)
- Indications Adenocarcinoma; Pancreatic cancer; Pancreatic ductal carcinoma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 22 Feb 2022 New trial record